肝纤维化无创诊断的研究进展

杨二娜; 曹武奎

doi:10.3969/j.issn.1001-5256.2017.11.035

肝纤维化无创诊断的研究进展

DOI: 10.3969/j.issn.1001-5256.2017.11.035

沧州中西医结合医院消化科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1974
- HTML全文浏览量: 43
- PDF下载量: 1109
- 被引次数: 0
出版历程
- 收稿日期: 2017-05-02
- 出版日期: 2017-11-20

Research advances in noninvasive diagnosis of hepatic fibrosis

Department of Gastroenterology, Cangzhou Integrated Traditional Chinese and Western Medical Hospital

摘要

摘要: 肝纤维化是多种慢性肝病共同的病理学基础,肝活组织检查作为目前评估和诊断肝纤维化的金标准,因其有创性和操作的高要求大大限制了其临床应用。介绍了近年来肝纤维化无创诊断在血清学和影像学等方面的发展,然而这些方法尚不能完全取代肝活组织检查,多种方法的相互补充,建立一个肝纤维化无创性综合诊断模型已成为今后的研究热点。
- 肝硬化 /
- 生物学标记 /
- 诊断 /
- 综述
Abstract: Hepatic fibrosis is the common pathological basis of various chronic liver diseases.Liver biopsy remains the gold standard for the assessment and diagnosis of liver fibrosis, but its invasiveness and high requirements for operation limit its clinical application.This article introduces the development of noninvasive diagnosis of hepatic fibrosis, such as serological and imaging techniques.However, these methods cannot completely replace liver biopsy.Therefore, a comprehensive noninvasive diagnosis model for hepatic fibrosis has become a research hotspot.
- liver cirrhosis /
- biological markers /
- diagnostic /
- review

HTML全文

参考文献(51)

[1]SEY MS, AL-HADDAD M, IMPERIALE TF, et al.EUS-guided liver biopsy for parenchymal disease:a comparison of diagnostic yield between two core biopsy needles[J].Gastrointest Endosc, 2016, 83 (2) :347-352.

[2]MAK KM, MEI R.Basement membrane type IV collagen and laminin:an overview of their biology and value as fibrosis biomarkers of liver disease[J].Anat Rec (Hoboken) , 2017, 300 (8) :1371-1390.

[3]AUMAILLEY M.The laminin family[J].Cell Adh Migr, 2013, 7 (1) :48-55.

[4]QI X, LI H, CHEN J, et al.Serum liver fibrosis markers for predicting the presence of gastroesophageal varices in liver cirrhosis:a retrospective cross-sectional study[J].Gastroenterol Res Pract, 2015, 2015:274534.

[5]QI X, LIU X, ZHANG Y, et al.Serum liver fibrosis markers in the prognosis of liver cirrhosis:a prospective observational study[J].Med Sci Monit, 2016, 22:2720-2730.

[6]TANG N, ZHANG Y, LIU Z, et al.Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis[J].Biomed Rep, 2016, 5 (1) :107-112.

[7]BUSK TM, BENDTSEN F, NIELSEN HJ, et al.TIMP-1 in patients with cirrhosis:relation to liver dysfunction, portal hypertension, and hemodynamic changes[J].Scand J Gastroenterol, 2014, 49 (9) :1103-1110.

[8]IRVINE KM, WOCKNER LF, HOFFMANN I, et al.Multiplex serum protein analysis identifies novel biomarkers of advanced fibrosis in patients with chronic liver disease with the potential to improve diagnostic accuracy of established biomarkers[J].PLo S One, 2016, 11 (11) :e0167001.

[9]MENG WD, FAN CS.Clinical research of serum parameter changes at different stages of development of NAFLD[J].Int J Lab Med, 2010, 31 (12) :1398-1399. (in Chinese) 孟卫东, 范存士.非酒精性脂肪性肝病各期血清学指标变化的临床研究[J].国际检验医学杂志, 2010, 31 (12) :1398-1399.

[10]MARFA S, MORALES-RUIZ M, OROD, et al.Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats[J].Biol Open, 2016, 5 (6) :858-865.

[11]MALEKI I, AMINAFSHARI MR, TAGHVAEI T, et al.Serum immunoglobulin A concentration is a reliable biomarker for liver fibrosis in non-alcoholic fatty liver disease[J].World J Gastroenterol, 2014, 20 (35) :12566-12573.

[12]MORIS D, DIMITROULIS D, KONTOS M, et al.The role of platelets on regenerating liver:thoughts beyond parenchymal proliferation[J].Liver Int, 2017.[Epub ahead of print]

[13]CEPEDA JA, SOLOMON SS, SRIKRISHNAN AK, et al.Serum fibrosis markers for the diagnosis of liver disease among people with chronic hepatitis C in Chennai, India[J].Open Forum Infect Dis, 2016, 3 (3) :ofw156.

[14]KARAGOZ E, ULCAY A, TANOGLU A, et al.Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients[J].Eur J Gastroenterol Hepatol, 2014, 26 (12) :1320-1324.

[15]CEYLAN B, FINCANCI M, YARDIMCI C, et al.Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B?[J].Eur J Gastroenterol Hepatol, 2013, 25 (5) :606-612.

[16]KASER A, BRANDACHER G, STEURER W, et al.Interleukin-6stimulates thrombopoiesis through thrombopoietin:role in inflammatory thrombocytosis[J].Blood, 2001, 98 (9) :2720-2725.

[17]CHO HJ, KIM SS, AHN SJ, et al.Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B[J].Clin Mol Hepatol, 2014, 20 (4) :347-354.

[18]ZENG DW, LIU YR, ZHANG JM, et al.Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B:a new noninvasive model for predicting liver fibrosis in HBV-related liver disease[J].PLo S One, 2013, 8 (10) :e77942.

[19]KRAWCZYK M, ZIMMERMANN S, HESS G, et al.Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease[J].PLo S One, 2017, 12 (3) :e0173506.

[20]WAI CT, GREENSON JK, FONTANA RJ, et al.A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C[J].Hepatology, 2003, 38 (2) :518-526.

[21]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.

[22]VALLET-PICHARD A, MALLET V, NALPAS B, et al.FIB-4:an inexpensive and accurate marker of fibrosis in HCV infection.comparison with liver biopsy and fibrotest[J].Hepatology, 2007, 46 (1) :32-36.

[23]IMBERT-BISMUT F, RATZIU V, PIERONI L, et al.Biochemical markers of liver fibrosis in patients with hepatitis C virus infection:a prospective study[J].Lancet, 2001, 357 (9262) :1069-1075.

[24]VOICAN CS, LOUVET A, TRABUT JB, et al.Transient elastography alone and in combination with Fibro Test (R) for the diagnosis of hepatic fibrosis in alcoholic liver disease[J].Liver Int, 2017.[Epub ahead of print]

[25]FORNS X, AMPURDANES S, LLOVET JM, et al.Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model[J].Hepatology, 2002, 36 (4 Pt 1) :986-992.

[26]SHETH SG, FLAMM SL, GORDON FD, et al.AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection[J].Am J Gastroenterol, 1998, 93 (1) :44-48.

[27]KODA M, MATUNAGA Y, KAWAKAMI M, et al.Fibro Index, a practical index for predicting significant fibrosis in patients with chronic hepatitis C[J].Hepatology, 2007, 45 (2) :297-306.

[28]PATEL K, GORDON SC, JACOBSON I, et al.Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients[J].J Hepatol, 2004, 41 (6) :935-942.

[29]TAMA M, NAYLOR P, PATEL S, et al.Overestimate of Fibrosis by FIBROSpectII in African Americans complicates the management of their chronic hepatitis C[J].J Clin Transl Hepatol, 2016, 4 (1) :12-19.

[30]ROSENBERG WM, VOELKER M, THIEL R, et al.Serum markers detect the presence of liver fibrosis:a cohort study[J].Gastroenterology, 2004, 127 (6) :1704-1713.

[31]CALES P, OBERTI F, MICHALAK S, et al.A novel panel of blood markers to assess the degree of liver fibrosis[J].Hepatology, 2005, 42 (6) :1373-1381.

[32]WU SD, WANG JY, LI L.Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model:a comparative study[J].World J Gastroenterol, 2010, 16 (4) :501-507.

[33]SUD A, HUI JM, FARRELL GC, et al.Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index[J].Hepatology, 2004, 39 (5) :1239-1247.

[34]ADAMS LA, BULSARA M, ROSSI E, et al.Hepascore:an accurate validated predictor of liver fibrosis in chronic hepatitis C infection[J].Clin Chem, 2005, 51 (10) :1867-1873.

[35]ZENG MD, LU LG, MAO YM, et al.Prediction of significant fibrosis in HBe Ag-positive patients with chronic hepatitis B by a noninvasive model[J].Hepatology, 2005, 42 (6) :1437-1445.

[36]AYKUT UE, AKYUZ U, YESIL A, et al.A comparison of Fibro Meter NAFLD Score, NAFLD fibrosis score, and transient elastography as noninvasive diagnostic tools for hepatic fibrosis in patients with biopsy-proven non-alcoholic fatty liver disease[J].Scand J Gastroenterol, 2014, 49 (11) :1343-1348.

[37]XU S, WANG Y, TAI DC, et al.q Fibrosis:a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients[J].JHepatol, 2014, 61 (2) :260-269.

[38]LOK AS, GHANY MG, GOODMAN ZD, et al.Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests:results of the HALT-C cohort[J].Hepatology, 2005, 42 (2) :282-292.

[39]ZHOU K, GAO CF, ZHAO YP, et al.Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B[J].J Gastroenterol Hepatol, 2010, 25 (9) :1569-1577.

[40]TOSON EA, SHIHA GE, EL-MEZAYEN HA, et al.Noninvasive estimation of liver fibrosis in biopsy-proven hepatitis C virus-infected patients:angiogenic fibrogenic link[J].Eur J Gastroenterol Hepatol, 2017, 29 (2) :199-207.

[41]LIU XD, WU JL, LIANG J, et al.Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients[J].World J Gastroenterol, 2012, 18 (22) :2784-2792.

[42]ZENG DW, DONG J, JIANG JJ, et al.Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase[J].World J Gastroenterol, 2016, 22 (43) :9586-9594.

[43]LAPADAT AM, JIANU IR, UNGUREANU BS, et al.Non-invasive imaging techniques in assessing non-alcoholic fatty liver disease:a current status of available methods[J].J Med Life, 2017, 10 (1) :19-26.

[44]LEI JW, TAN BB, LI WB, et al.Value of transient elastography measured with Fibro Touch in the diagnosis of liver fibrosis in chronic hepatitis patients with hepatocellular carcinoma[J].Chin J Med Offic, 2017, 45 (9) :930-933. (in Chinese) 雷洁雯, 谭碧波, 李万斌, 等.Fibro Touch瞬时弹性成像诊断慢性乙型肝炎合并肝癌患者肝纤维化程度应用研究[J].临床军医杂志, 2017, 45 (9) :930-933.

[45]FRIEDRICH-RUST M, SCHWARZ A, ONG M, et al.Realtime tissue elastography versus Fibro Scan for noninvasive assessment of liver fibrosis in chronic liver disease[J].Ultraschall Med, 2009, 30 (5) :478-484.

[46]WU T, WANG P, ZHANG T, et al.Comparison of two-dimensional shear wave elastography and real-time tissue elastography for assessing liver fibrosis in chronic hepatitis B[J].Dig Dis, 2016, 34 (6) :640-649.

[47]FRULIO N, TRILLAUD H.Ultrasound elastography in liver[J].Diagn Interv Imaging, 2013, 94 (5) :515-534.

[48]SCHMILLEVITCH J, CHAMMAS MC, PUGLIESE V, et al.A-coustic radiation force impulse (ARFI) elastography compared with biopsy for evaluating hepatic fibrosis after liver transplantation:a cross-sectional diagnostic study[J].Sao Paulo Med J, 2016, 134 (6) :513-518.

[49]ELHOSARY YA, SALEH SM, EZZAT WM, et al.Diagnostic accuracy of acoustic radiation force impulse (ARFI) in diagnosis of liver fibrosis among egyptian patients with chronic HCV infection[J].Open Access Maced J Med Sci, 2016, 4 (3) :374-380.

[50]ZHANG J, GUO Y, TAN X, et al.MRI-based estimation of liver function by intravoxel incoherent motion diffusion-weighted imaging[J].Magn Reson Imaging, 2016, 34 (8) :1220-1225.

[51]NIU M, DENG DY, LI YPF, et al.Values of MRE in diagnosis of stages of hepatic fibrosis:a Meta-analysis[J].J Jilin Univ:Med Edit, 2017, 43 (4) :787-793. (in Chinese) 牛猛, 邓大勇, 李云鹏飞, 等.磁共振弹性成像对肝纤维化分级诊断价值的Meta分析[J].吉林大学学报:医学版, 2017, 43 (4) :787-793.

施引文献

资源附件(0)

访问统计